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INTRODUCTION
Normal function and development of the kidney has a demonstrable dependence on apoptosis. Apoptosis of cells within the kidney during organ development and during regeneration of tubules following renal damage insures proper nephron development and tubular repair. Apoptosis also protects the kidneys by eliminating cells with DNA damage or viral infection. Numerous toxicants have been reported to trigger or block the intracellular death machinery, resulting in abnormal regulation of apoptosis. Apoptosis is a general mechanism by which toxicants can mediate a wide range of pathologic organ responses, from agenesis to tumor formation. A review of the multiple disease syndromes and functional changes that result from abnormal regulation of apoptosis under-scores the vital role this process plays in maintenance of normal kidney function. In a toxicopathologic context, these renal functional changes and diseases highlight the potential for a variety of toxicants to engage the process and impair renal function. The overall purpose of this review is to highlight the functional role of apoptosis in the kidney and some of the molecular factors and toxicants that regulate this process.
Apoptosis vs Other Forms of Cell Death
Although the term apoptosis was first introduced in the early 1970s by Kerr, Wyllie, and Currie (57) , Glucksmann and colleagues described the morphologic alterations associated with the process in kidney cells during the early 1950s (31) . The apoptotic response (which can be induced by normal or pathologic stimuli) is a highly organized and complex cascade of molecular events which culminates in cleavage of DNA and proteins and FIG. 1.-Cell deletion by apoptosis in proximal tubular epithelium associated with hydronephrosis. a) Renal autopsy material from a human patient with bilateral hydronephrosis. H&E. X600. b) Rat kidney proximal tubular epithelial cells undergoing early apoptosis (arrows). Cell shrinkage, chromatin condensation, and margination of the nuclear chromatin are clearly shown in a cluster of apoptotic bodies. H&E. X 1440. Reproduced with permission from Gobe and Axelsen (32) . the disassembly of cell structural components. The characterization of apoptosis is derived from the distinct morphologic changes that occur as a consequence of these molecular events. The group of distinct morphologic changes that the apoptotic cell displays includes shrinkage and fragmentation of the nucleus, blebbing, and cell fragmentation into membrane-enclosed vesicles (apoptotic bodies) that can be observed using light or electron microscopy (Fig. 1 ). There is no inflammatory response mounted against apoptotic bodies in the kidney partially because these bodies are quickly ingested by neighboring cells or shed into the tubular lumen. Many of the biochemical changes that occur during apoptosis can be identified by techniques such as in situ end labeling or terminal deoxytidyl transferase-mediated dUTP nick-end labeling (ISEL or TUNEL; which identifies DNA strand breaks with a 5' overhang), antihistone antibodies (which detect histone bound DNA fragments), or Annexin V detection (used in live cells), which detects the early externalization of phosphatidylserine from the inner plasma membrane to the cell surface that occurs during apoptosis. These techniques can be used in practice, along with morphology, to quantify and identify apoptotic cells in tissues or cell culture.
In contrast to apoptosis, in which cells shrink and lose volume, cells can also respond to pathologic stimuli by swelling. Cell swelling appears to be mediated by inactivation of the sodium-potassium ATPase, which increases influx of fluid from the extracellular environment. During this process, large cytoplasmic fluid-filled blebs and swollen organelles apppear and karyolysis typically ensues (82) . The term &dquo;oncosis&dquo; has been suggested to describe the prelethal phase of cell death that fits this description ; however, a universally acceptable term to describe this stereotypical morphology is still the subject of discussion.
Following either an apoptotic or oncotic/swelling pathway, cells can display a series of postmortem or necrotic changes. Apoptotic bodies typically undergo apoptotic necrosis within the phagolysosomes of the engulfing cell (Fig. 2 ), whereas swollen or oncotic cells undergo necrosis within the tissue. If the apoptotic cell is not ingested, the cell will proceed to a necrotic phase in the tissue, and cellular contents can spill into the extracellular space, inciting inflammation. As a result, the original cell death pathway taken by the cell to reach a necrotic phase may be obscured in some instances (142) . Although the morphology of apoptosis, oncosis, and necrosis are often compared and discussed, apoptosis has a highly regulated role in the kidney that is uniquely associated with maintenance of a variety of vital renal functions. The importance and consequences of apoptosis are made readily apparent upon examination of the consequences of its abnormal regulation in kidney.
Apoptosis during Metanephric Development
The metanephric kidney develops from 4 principal types of cells: the nephritic epithelium, the nephrogenic mesenchyme, the capillary endothelium, and nerve cells (23, 107) . The nephritic epithelium, also called the ureteric bud, is an outgrowth of the wolffian ducts and forms around E10.5 in the murine system. This precursor of the collecting duct system grows caudally from the early fetal kidneys, ultimately entering the nephrogenic mesenchyme. Barasch and colleagues used an in vitro system of ureteric bud cell lines to show that the ureteric bud stimulates nephrogenesis via 2 distinct induction signals.
The ureteric bud secretes factors that rescue the mesenchymal cells from apoptosis, whereas diffusion-limited basolateral factors trigger the conversion of mesenchyme into epithelium (4) . Newly differentiated epithelial cells proliferate and eventually form the proximal convoluted tubules, loop of Henle, and distal convoluted tubules of the nephron (42) . The branches of the ureteric bud join with the distal convoluted tubules to form collecting FIG. 2.-Cell engulfment and secondary necrosis. Primary cultures of rat proximal tubules were exposed to TNFa in vitro and processed for electron microscopy. A proximal epithelial cell is shown in the cytoplasm of a neighboring cell after phagocytosis. The engulfed cell shows morphologic evidence of secondary necrosis. ducts and the ureter. For an extensive review of kidney development, see the reviews by Davies (15) and Lechner and Dressler (74) .
Apoptosis is the death pathway for the uninduced, undifferentiated mesenchymal cells and cells residing in the walls of tubular structures (14) , such as type B intercalated cells of the medullary collecting duct (60) . Without the inducing effect of ureteric bud, the nephrogenic mesenchyme undergoes widespread apoptosis (64) . The thin ascending limb of the loop of Henle is derived from the thick ascending limb by apoptotic deletion of the thick ascending limb followed by cell transformation (61) . The type A intercalated cells are removed by extrusion from the epithelium. In embryonic mouse kidney, a larger portion of apoptotic cells are engulfed by hematopoietically derived &dquo;professional&dquo; macrophages than by mesenchymal cells when compared with the adult kidney, in which the neighboring parenchymal cells engulf the majority of apoptotic cells (6) .
Apoptotic deletion of rat kidney cells during development appears to follow a specific temporal pattern.
Within the nephrogenic zone, 2.7% of the cells are apoptotic during the embryonic period (14) . After birth, this percentage declines to a basal level of 0.15% by the fourteenth postnatal day. A second peak occurs in the medullary papilla at postnatal days 6-7 when the percentage of apoptotic cells reached 3.2%. By postnatal day 14, the percentage of apoptotic cells in the papilla had declined to less than 0.1 % (14) . Peak apoptosis in the medullary papilla correlates temporally with deletion of the thick ascending limb cell during the formation of the thin ascending limb of the loop of Henle (61) . Renal exposure to chemicals in utero may have a pattern of effects that depends on the cellular events during that developmental period.
THE ROLE OF APOPTOSIS IN PATHOGENESIS OF RENAL DISEASE
A thorough review of the disease states that result from deregulation of apoptosis highlights the potential mechanisms by which toxicants can affect apoptosis in the kidney. Most of the renal diseases that are associated with apoptotic deregulation result in loss of kidney function, abnormal development, or abnormal growth. Many of the renal diseases associated with apoptosis are summarized in Table I .
Pathologic Apoptosis during Kidney Growth and Development
Deregulation of apoptosis during development is involved in the pathogenesis of congenital renal dysplasia and congenital polycystic kidney disease (156, 163) . In the pathogenesis of congenital renal dysplasia, there is decreased branching of the uteric bud and failure of the renal mesenchyme to differentiate into nephrons (156) . It is postulated that increased numbers of apoptotic cells in the mesenchyme surrounding dysplastic tubules may lead to spontaneous involution of the dysplastic kidney in congenital renal dysplasia (156) . In polycystic kidney disease, apoptosis occurs in interstitium and epithelium of proximal and distal tubules and within the epithelial lining of cysts, leading to destruction of functional renal tissue (156) . Epithelial cell proliferation and apoptosis appear to be required for deregulation of kidney homeostasis in human autosomal dominant polycystic kidney disease (ADPKD). Deregulation of apoptosis in autosomal recessive polycystic kidney disease (ARPKD) appears to be associated with altered bcl-2 expression. In the murine model of ARPKD (cpklcpk), increased apoptosis is correlated with a lack of bcl-2 expression (121) . However, in the c-myc transgenic model of ADPKD, both bcl-2 and c-myc levels appeared elevated in correlation with increased apoptosis and proliferation in cystic epithelium, and both processes are important mediators of cystogenesis (73) . The relationship between bcl-2 to specific cell populations (proliferating vs apoptotic) was not reported in these studies; thus, bcl-2 elevation may occur only in proliferating cells.
Glomerular Diseases
Apoptosis is responsible for the progressive cell loss that occurs in the pathogenesis of glomerular sclerosis. Apoptotic cells accumulate in the glomeruli, which allows correlation of glomerular sclerosis index and apoptotic index (number of apoptotic cells divided by the number of normal cells) with a decline in kidney function (117, 128) . Interestingly, deletion of glomerular cells is accompanied by extracellular matrix accumulation in the rat kidney model of the disease (128) . The signal that induces apoptosis of glomerular cells is unknown, but reactive oxygen species are prime candidates because they are common mediators in glomerular disease and tubular injury. In contrast to glomerular sclerosis, during the chronic proliferative phase of systemic lupus erythematosus (SLE) there is a decrease in the number of apoptotic cells and an increase in the number of proliferating cells, causing an imbalance in tissue homeostasis (123) .
It is also of interest to note that defective clearance of apoptotic bodies also indirectly participates in the pathogenesis of SLE. Histone-bound DNA complexes with high affinity for the glomerular basement membrane are released from apoptotic cells and deposited in the glomerulus, inciting an immune response and causing glomerular injury (110, 111, 124, 150) .
Obstructive Uropathy
Acute unilateral ureteral obstruction due to physical obstruction or congenital anomalies results in hydronephrosis and renal failure. In the neonatal and adult kidney, impairment of renal growth and tubular atrophy are associated with an increase in apoptosis, primarily in the distal tubular epithelium (56, 143) . In addition, neonatal rat kidneys appear to be more sensitive to apoptosis induced by 2 wk of ipsilateral complete renal obstruction (12) . The increase in apoptosis following obstruction is rapid; apoptotic cells appear after only 3 days of obstruction. The differential response of the neonatal kidney and adult kidney may be due to a greater decline in the expression of inhibitors of apoptosis such as clusterin, bcl-2, or epidermal growth factor (EGF) and greater reninangiotensin activation in the neonatal as compared with the adult kidney. Apoptosis-inhibiting pathways may be key to the development of a rational treatment for obstructive nephropathy. Indeed, EGF administered subcutaneously to rats with experimentally obstructed ureters suppressed apoptosis and promoted regeneration of epithelial cells in both the distal tubule and collecting ducts (55) .
Renal Neoplasia
Renal apoptotic index has been positively correlated with numerous prognostic factors of renal cell carcinoma. Tumor growth, grade, stage, and proliferative index correlate positively with an increase in apoptotic index and advanced staging of the tumor (139) . In addition, the susceptibility of Wilms' tumor cells to apoptosis appears to partially determine prognosis and responsiveness to treatment. The sensitivity of Wilms' tumor cells to apoptosis is p53 dependent (5) . Mutations in p53 that impart resistance to apoptosis are associated with lack of response to chemotherapy and a poor prognosis. However, the prognostic value of p53 is not consistent in all renal tumors. Renal cell carcinomas displayed mutant p53 in 28% of the cases examined, and the presence of mutated p53 was positively correlated with a decrease in apoptosis. Although the prognostic significance of decreased apoptosis was high with a univariate analysis, in a multivariate analysis it did not appear to be a significant independent prognostic factor (45, 135) . The prognostic significance of bcl-2 protein levels in renal neoplasia is also unclear; in I study, overexpression of bcl-2 was noted in all renal neoplasms examined (9) , yet in another study expression of bcl-2 was not correlated with the prognosis of renal cell carcinoma (45) . Although the prognostic value of many apoptotic regulators is unclear, the regulatory roles and expression patterns of p53 and bcl-2 in renal cancers are the intense focus of ongoing study.
Apoptosis in Repair of Renal Damage
The regeneration process of the damaged kidney would not be successful without an increase in apoptosis. Acute ischemia followed by reperfusion induces acute tubular necrosis and apoptosis of the distal tubular epithelium (2) . During the regeneration phase of tubular injury, there is an increase in cellular proliferation and a concomitant increase in apoptosis. Excess cells produced during regeneration are removed both by desquamation into the lumen and by apoptosis (119) . Following acute necrosis of proximal tubules, there are 2 apoptotic peaks that occur between 1 and 3 days and around 7 days after the injury. By 4 wk, the level of apoptosis decreases to baseline levels (119, 133) .
In many cases, acute damage to proximal tubule epithelial cells appears to stimulate apoptosis within the distal tubules. Gentamicin-induced necrosis of proximal convoluted tubules was accompanied by a compensatory increase in apoptosis in the cortical and outer stripe of the medullary distal convoluted tubules (89) . The peak level of apoptosis in the distal tubules occurred 2 days after the initial injury to the proximal tubules, whereas the peak in the proximal tubules occurred 8 days after injury (89) . The rapid apoptotic and proliferative response of the distal tubule to proximal tubular damage implies that there is an extracellular signal originating from the damaged cell population.
In addition to its role in tubular injury, apoptosis is also involved in repair of glomerular lesions. Induction of crescentic glomerulonephritis is followed by mesangial cell proliferation, extracellular matrix accumulation, and decreased renal function ( 118) . The apoptotic index increased 7 days after induction and remained elevated after inflammation subsided. The role of apoptosis in glomerulonephritis appears to be to reduce hypercellularity of glomerulonephritis during repair, which controls the size of the glomerular population and clears excess cells. Ultimately apoptosis is required for recovery of normal glomerular function.
In a few instances, rather than aiding the healing process apoptosis augments renal damage. For example, analgesic nephropathy, induced in rats by a single subcutaneous injection of bromoethlylamine-1-hydrobromide, is characterized by cell proliferation and apoptosis; however, the increase in apoptosis appeared to lead to exaggerated cortical tubular atrophy (32) . Renal atrophy in this experimental model occurred because increased apoptosis was unbalanced by a compensatory increase in cell proliferation.
Apoptosis in Renal Transplantation
Apoptosis appears to contribute to the pathogenesis of both acute and chronic rejection of renal allografts. In an acute rejection, apoptosis occurs in the renal tubular epithelium, leading to tubular atrophy (48, 54, 113) . Molecular executors of apoptosis, such as fas-ligand, granzyme B, and perforin, are elevated in the renal tubular epithelium of the transplanted kidney (54, 114) . Although the presence of these factors correlates well with acute rejection, the absence of fas, fas-ligand, granzyme B, or perforin has limited prognostic value for acute renal transplantation because rejection can occur in the absence of these factors ( 114) .
Chronic transplant nephropathy is characterized by a sustained and irreversible loss of renal function accompanied clinically by proteinuria and hypertension (26) . Chronic renal allograft rejection is characterized by a gradual progression, suggesting persistent low grade injury. In support of this possibility, the mean number of apoptotic cells was 4 times higher in the proximal and distal tubules of rejected kidneys from patients with chronic renal allograft rejection (71) . Apoptosis in longterm renal allographs may be useful as a biochemical marker of allograft rejection or, more importantly, may be correlated with loss of renal function.
TOXICANT-INDUCED APOPTOSIS
A growing group of toxicants and natural toxins that affect a variety of cellular factors are associated with alterations in renal apoptosis. This group is comprised of various heavy metals, pharmacologic agents, naturally occurring toxins, and viral toxins (summarized in Tables   II and III) . Although these chemicals are linked by apoptosis in the kidney, the mechanisms and molecular pathways employed are diverse.
Heavy Metals
Various heavy metals have been reported to induce apoptosis in renal cells, but in some cases it is unclear what molecular pathways are primarily involved in the cellular response. For example, inorganic mercuric chloride induces apoptosis of porcine renal proximal tubule cells (LLCPK), although it appears to activate both proapoptotic and antiapoptotic pathways. Exposure of LLCPK1 cells to HgC12 causes a rise in intracellular hydrogen peroxide level and induces production of antiapoptotic proteins such as bcl-2 and bcl-x (20, 87) . In this case, elevation in antiapoptotic bcl-2 family members may be part of a generalized elevation of redox-sensitive genes in response to oxidative stress.
Cadmium induces apoptosis of proximal convoluted tubule cells when administered to dogs per os and when primary cultures of renal proximal tubules isolated from canine kidney are exposed to 100 Iillv1 CdCl, (39, 41) . Normally, cadmium is rapidly bound to methallothionein in the liver, and binding of cadmium to form a cadmiummetallothionine complex (Cd-MT) is generally considered to be protective to cells. However, it has been hypothesized that the Cd-MT complex may play a mechanistic role in renal apoptosis by increasing nuclear accumulation of cadmium and inducing nuclear morphology (40) . Cadmium has been localized to the cytoplasm and nucleus of proximal renal epithelial cells, and apoptosis may be protective in cadmium toxicosis because the apoptotic cells loaded with Cd-MT are shed into the urine, providing a unique mechanism for cadmium excretion ( 134) .
Several antineoplastic agents are included in the group of pharmacologic agents shown to induce apoptosis in renal epithelial cells. Cisplatin induces apoptosis at low concentrations (8 pLM), resulting in cell loss over the space of several days that appears to be mediated by generation of reactive oxygen species (76) . Another group of nephrotoxicants causes apoptosis in association with cytoskeletal disorganization in rat renal proximal tubules. Members of this group include S-(1,2-dichlorovinyl)-Lcysteine (DCVC), cytochalasin D, and dithiothreitol (147) . DCVC also induces increased intracellular calcium, mitochondrial damage, and oxidative stress, all of which may also play a role in induction of apoptosis (145, 147) .
Exposure of kidney cells in vitro or in vivo to ionizing radiation induces apoptosis. Fetal kidneys exposed to radiation underwent extensive apoptosis, with the highest amount of apoptosis occurring within 24 hr of exposure. In the fetal kidney, the most sensitive cells seemed to be the rapidly dividing cells of the developing nephrons, whereas those cells within the more mature nephrons suffered less damage (33) . Adult mesangial cells are also susceptible to the apoptosis-inducing effects of ionizing radiation (8) . Gamma radiation does not have similar apoptotic-inducing effects on the kidney or other radoresistant tissues such as heart, skeletal muscle, brain, liver, and lung (62) . However, in radiosensitive tissues gamma radiation induces apoptosis and upregulation of bax protein.
Natural Toxins
Many natural toxins are also potent inducers of apoptosis. Verocytotoxin (produced by Escherichia coli) induces apoptosis, which is potentiated by tumor necrosis factor beta (TNF[3) (144) . TNF[3 increases the number of verocytotoxin receptors on the endothelial cell surface and has been linked to hemolytic uremic syndrome (101, 148) . Ricin (from the castor bean) has been reported to induce apoptosis of Vero cells (derived from green monkey kidney) by inhibiting ribosomal protein synthesis (154) .
Many natural toxins contaminate food and water supplies, increasing their potential for renal exposure. Toxins such as Alternaria alternata lycopersici (AAL) and fumonisin are sphingonine analog mycotoxins that induce apoptosis in the kidney (21, 152) . AAL and fumonisin induced apoptosis in tubular epithelial cells that was most prevalent in the outer medulla and associated with development of hydronephrosis (77, 140) . The mechanism leading to apoptosis is unknown, but AAL and fumonisin are associated with disruption of sphingolipid metabolism by inhibition of ceramide synthase and/or inhibiting nacyl transferase (88, 151) . Exogenous ceramide triggers apoptosis in numerous cell types (49, 136) , and because sphingolipids are found in many foods such as beef and cheese, intestinal metabolism of sphingolipids to ceramides could potentially supply the kidney with an exogenous source of ceramide (109) . For a review of the sphingomyelin pathway and apoptosis, see Pena et al, 1997 (95) .
Similarly, the natural toxins okadaic acid, microcystin LR, and ochratoxin A are important inducers of apoptosis of renal cells. Ochratoxin A is a product of strains of Aspergillus and Penicillium fungi (149) that induces apoptosis in kidney cells (112) . Ochratoxin A may induce apoptosis via its effect on mitochondrial respiration and reduction in total cellular oxygen consumption (1) . Unlike ochratoxin, microcystin LR and okadaic acid are protein phosphatase inhibitors that induce apoptosis of renal epithelial cells in vitro (17, 58, 80) . The regulation of apoptosis by phosphatase inhibitors appears to involve complex kinase signalling pathways. H-ras oncogene expression increases susceptibility to okadaic acid-induced apoptosis, whereas the expression of the ras oncogene decreases susceptibility to other induction mechanisms of apoptosis (16) . Other toxins have been reported to cause apoptosis in transformed renal cells. Curcumin, a yellow dietary pigment found in the spice tumeric, has been shown to cause apoptosis of renal cancer cells by inhibiting protein kinase C (52) , and the mycotoxin gliotoxin has been found to cause apoptosis in Wilm's tumor cells (153) .
As in many other tissues, viral toxins mediate apoptosis in kidney. Viruses or viral proteins that stimulate or inhibit renal apoptosis (Table III) (98, 104, 127, 137, 138, 161) .
MOLECULAR CONTROL OF RENAL APOPTOSIS
A large number of cellular factors have been proposed to regulate the apoptotic response following a wide variety of induction mechanisms and in numerous cell types. The actual role many of these factors play depends on the signal that triggers apoptosis and the cell type in which the response is induced. Tremendous progress has been made in understanding the intracellular mechanisms of apoptosis. An emerging theme is that apoptosis occurs in 3 phases: initiation, effector, and final. The final common pathway includes caspases, endonucleases, and possibly changes in mitochondrial function. The factors that lie upstream of the final common pathway are the initiators and effectors of apoptosis and are often unique to a particular cell or induction method. Initiation factors include TNF receptor and ligands, growth factors, and changes in extracellular matrix. The effector phase includes factors such as cell signaling proteins and transcription factors that mediate the intracellular effects. These are the factors that will provide suitable targets for regulation of apoptosis in undesirable cell populations or for protection of normal cells from therapies intended to kill neighboring tumor cell populations. Many of the factors that have been currently identified as regulators of apoptosis in the kidney are included in the summary Diagram 1. Table IV lists a group of recommended review articles for some of the molecular regulators.
TNF and Fas
The TNF receptor family is one of the best characterized of the receptor-mediated cell death pathways. The family includes the cell surface receptor CD95 (also called Fas or APO-1), nerve growth factor receptor, CD40, and CD30 (120) . TNF and the fas-ligand (fas-L) are the cytokine ligands of the TNF superfamily, which upon binding to their receptors engages the apoptotic pathway via a region of intracellular homology named the death domain (148) . Neither receptor has intrinsic cat-alytic activity, but through the death domain they induce a cascade of protein interactions that result in activation of apoptotic executioners such as caspases (85) ; for review, see Baker and Reddy (3) . The regulation of Fas and TNF pathways may also involve the activation of the proapoptotic mitogen-activating protein kinases (MAPK), p38 (35) and Jun N terminal kinase (JNK), and sphingomyelinase activation and generation of sphingomyelin metabolites such as ceramide (47, 131, 136) . There are numerous instances in which TNF receptor ligands are elevated in vivo, increasing susceptibility of renal cells to apoptosis and renal damage. TNFa levels are increased in rat glomeruli during adriamycin or puromycin aminonucleoside-induced hydronephrosis (36) . TNF causes apoptosis in numerous renal cells in culture, including mouse mesangial cells, LLCPK, and mouse proximal tubule cells (79, 92, 96) . Decreased susceptibility of renal tumor cells to TNF-induced apoptosis is also an important mechanism of chemotherapeutic resistance (157) . In addition, TNF elevation may also potentiate the apoptotic effects of exogenous toxins or chemicals. TNFa increases the apoptotic effects of verocytotoxin-producing E. coli by increasing the number of verocytotoxin receptors on human renal endothelial cells (148) .
CD95 differs from the TNF receptor in that normal human renal cells do not express the CD95 receptor (54) . CD95 receptor mRNA expression is increased in diseased kidney and human renal allografts undergoing acute rejection (114) and in cultured renal epithelial cells exposed to TNF, E. coli lipopolysaccharide, interleukin 1-beta, or gamma interferon (92) . Fas-L expressed on lymphocytes triggers apoptosis in renal cell carcinoma cell lines and murine mesangial and tubular epithelial cells (92, 141) .
Cysteine Aspartic Serine Proteases
Caspases are a group of cysteine aspartic serine proteases. Activation of caspases (which exist primarily as proenzymes intracellularly) appears to be associated with cleavage of critical cellular substrates during apoptosis.
Substrates for these proteases include other caspases, intracellular proteins such as polyADPribose polymerase, and lamins; for an extensive review of caspases, see Cohen (cited in Table IV ). A common feature of the caspase substrates identified thus far is that they all play a vital role in maintenance of cell homeostasis and critical cell functions. In the caspase family, interleukin-1(3 converting enzyme and Nedd have been localized within the murine fetal kidney (69) and CPP32 (caspase 3) has been localized within the human renal tubular epithelium (65) . The essential role of caspases in apoptosis appears to be in the final or execution phase; however, many question; about caspase activation in specific induction pathways and in various tissues remain.
Granzyme B
Granzyme B is a serine esterase produced by cytotoxic T lymphocytes and natural killer cells. In most cases granzyme B enters the targeted cell via perforin-mediate4 pore formation. However, granzyme B can cross the cel I lular membrane independent of perforin (115) . Within th targeted cell, granzyme B causes proteolysis of intracel lular components and apoptosis (155) . Increased levels of granzyme B and perforin correlate with acute rejection of renal transplants (70, 114, 126, 129) . Studies on renal cells in culture indicate that expression of the nuclear kinase Weel can protect against granzyme B-and perforin-induced apoptosis (11) .
Glucose
Glucose is an important molecular trigger of apoptosis of the renal cells. Alterations in glucose metabolism that occur in diabetes or toxicant exposure may increase renal susceptibility to apoptosis. The mechanism by which glucose modulates apoptosis appears to involve alteration of bax : bcl-2 ratios in murine tubular epithelial cells (91) . By decreasing the levels of bcl-2 and increasing bax levels, incubation with 25 mmol glucose engages the apoptotic process (91) . During murine kidney development, 30 mmol/L glucose decreases the synthesis of perlecan, a heparin sulfate proteoglycan, disrupting epithelial mesenchymal cell-to-cell interactions, which accelerates apoptosis and causes renal atrophy (53) . Therefore, it appears as though glucose mediates apoptosis via alterations in cell-to-cell interactions and other mechanoreceptors.
The bcl-2 Family
The bcl-2 family of proteins is a closely associated group of intracellular pro-and antiapoptotic regulators. Six members of the family have been specifically mapped to various locations within the kidney; bcl-2, bcl-xl , bfl-1, bax, bak, MCL-1, and BAD (9, 19, 22, 37, 66, 121) .
During renal development, bcl-2 expression has been reported in the murine ureteric bud and tubular structures (90) and in the induced human mesenchymal cells (9) . The tissue distribution of bcl-2 family members in kidney is outlined in Table V . Intracelluarly, Bcl-2 is localized with mitochondrial, endoplasmic reticulum, and nuclear membranes; for review of the bcl-2 family, see Korsmeyer et al (63) and Kroemer (68) . In numerous models of apoptosis, bcl-2 or BCIXL promote cell survival by inhibiting apoptosis.
The antiapoptotic proteins of the bcl-2 family are uniquely associated with regulation of apoptosis in the kidney. During murine development, a lack of bcl-2 results in increased apoptosis and cystogenesis (121, 122) . In contrast, overexpression of bcl-2 may contribute to the development of renal neoplasia. The mechanism(s) by which bcl-2 family members function is presently unclear. There are numerous biological effects of bcl-2 on intact cells and as a result, various mechanisms have been proposed to explain how the bcl-2 family members functionally regulate apoptosis. The proposed mechanisms of antiapoptotic function include protection of membranes from oxidant damage, antagonism of proapoptotic proteins such as bax, and protection of organelle membranes by regulating permeability via ion channel formation (25, 84, 108) . In addition, serine phosphorylation appears to modulate the function of some bcl-2 family members such as bcl-2 and BAD (38, 162) .
Bax is a prototypical member of the bcl-2 family which is proapoptotic. In vivo patterns of the bax gene differ from bcl-2, and the expression patterns only partially overlap, meaning Bax is not always dependent on bcl-2 for proapoptotic function. In mouse kidney, bax im-munostaining was moderate in the epithelial cells of the collecting tubules, as well as the nephrons, but was absent from the cells of the glomerulus. Proposed mechanisms of proapoptotic functions of proteins such as bax include intrinsic pore-forming activity and pH-and voltage-dependent ion channel formation. There appears to be a change in the intracellular location of bax during apoptosis. Wolter et al (157) recently reported a movement of bax from the cytosol to the mitochondria during apoptosis of Cos-7 green monkey kidney epithelial cells. In a general sense, renal epithelial cells are unique in their physiological relevance to many of the proposed mechanisms of bcl-2 function since ion channels, response to oxidant stress, and pH regulation are normal functions carried out by renal epithelial cells in vivo.
p53
High expression of p53 protein in murine renal development is associated with increased apoptosis and kidney failure in mice (34) . p53 is a zinc finger transcription factor that induces the transcription of a variety of proteins including p21, Gadd45, and Gaddl53 (50, 51) , which are involved in cell cycle arrest and DNA repair. Transcription of p53 is inhibited by adenovirus E 1 B protein (103), Epstein-Barr virus E6 proteins (138) , WT 1 expression (81) , bcl-2 (13) , and bfl (19) . The mechanism by which p53 mediates apoptosis is presently unclear. For a comprehensive review of p53 function and regulation, see Table IV .
WT-1
The Wilms' tumor suppression gene (WT-1) is an important regulator of apoptosis in the kidney that has been reported to stimulate and suppress apoptosis of renal cells (24) . The mechanism by which WT-1 regulates apoptosis is unclear; however, in human kidney cells WT-1 suppresses the synthesis of bcl-2 and c-myc and inhibits p53induced apoptosis in rat kidney (43, 81) . The critical role for WT 1 in kidney development could not be better demonstrated than by the consequences of WT-1 mutation. Homozygous mutation of murine WT-1 is lethal and results in failure of the development of many organs including the kidney (67) . Heterozygous mutations have been associated with formation of Wilms' tumor (78) and urogenital anomalies associated with Denys-Drash syndrome (94) .
Growth Factors
Growth factors suppress apoptosis in most cell populations studied. In contrast, growth factor deprivation induces 1 of 2 responses: quiescence or apoptosis. The response of the cell to growth factor deprivation depends upon the state of the cell at the time of withdrawal and regulatory proteins such as C-myc. Apoptosis in the metanephric mesenchyme is prevented by EGF and basic fibroblast growth factor. In the adult kidney, acceleration of renal repair following tubular damage can be achieved by exogenous administration of growth factors (132) . Classically, growth factors were thought to contribute to renal repair by activating cell signaling pathways that induce cell proliferation. However, it is now apparent that growth factors also serve to inhibit apoptosis in the kidney both during development and during renal repair of adult kidneys independent of proliferative effects. Indeed, EGF was shown to abrogate apoptosis of renal epithelial cells without affecting mitotic index (14) . Similarly, exogenous insulin growth factor (IGF-1), EGF, or hepatocyte growth factor (HGF) administered in the early phase of postischemia accelerates renal tubule recovery (46) . The precise roles of HGF and IGF-1 in apoptosis in the kidney is unclear; however, IGF-1 prevented apoptosis in serum-deprived PC-12 cells and was correlated with an increase in bcl-x mRNA and protein (93) . After ischemic renal injury, IGF-I expression is localized to the regenerative zones of the renal tubule (72) . The therapeutic effects of HGF have also been demonstrated in druginduced nephrotoxicity, which is associated with suppression of apoptosis (158) .
Extracellular Matrix Interactions
Proper maintenance of interaction with the extracellular matrix is necessary to prevent apoptosis in kidney cells. Anoikis (pronounced an-o-6-kis) is a term used to describe the entry of epithelial or endothelial cells into apoptosis when they lose contact with the extracellular matrix (28) . This activation of apoptosis through detachment is especially important in vivo because it insures that detached cells are unable to proliferate or survive in an inappropriate location after detachment. The intracellular signals regulated by extracellular matrix interaction at the cell surface appear to be mediated through the integrin family of cell surface proteins (105, 125) . The intracellular signals linking the extracellular matrix to cell response pathways include phosphoinositide 3-OH (PI3) kinase, Ras, focal adhesion kinase, and the mitogen-activated protein kinase pathways (7, 30, 59) . Disrupting the ability of alpha 2 beta I integrin to bind to type I and type IV collagen caused increased apoptosis in Madin-Darby canine kidney cells (105) . Moreover, inhibition of focal adhesion kinase, a cytoplasmic tyrosine kinase that acts as an integrin transducer, induces apoptosis (30) . Indeed, cell matrix-regulated signal pathways may mediate the function of antiapoptotic and proapoptotic proteins such as bcl-2 (29, 163) . Phosphorylation of BAD (a proapoptotic member of the bcl-2 family) by AKT in a PI3kinase-dependent pathway inactivated BAD and promoted cell survival (18) . Similarly, cell-to-cell interactions that sensitize cells to anoikis down-regulate bcl-2 mRNA and protein (29) . Alternatively, the cells connection to the extracellular matrix may influence apoptosis by directly influencing cell spreading. The degree of cell spreading was key to regulating apoptosis in endothelial cells (10) . Because the cell shape is dictated by the number of attachments the cell has with the basement membrane, an increase in the area that a cell can occupy will allow the cells to spread and suppress cell death in the remaining cells. An example of a situation in which the area for cell spreading increases can be found in acute tubular necrosis when cells are lost from the basement membrane because of tubular damage. Clusterin Clusterin (sulfated glycoprotein-2 [SGP2], testosterone-repressed prostate message-2 [TRPM-2], or apoplipoprotein) appears to be uniquely associated with apoptosis in the kidney. Although the protein is not a critical regulator of apoptosis, its role in cell aggregation of renal epithelial cells may link it mechanistically to apoptosis in the kidney (27) . Clusterin expression may increase as a protection mechanism in the damaged tubules, promoting cell interaction and cell signaling in the surviving cells. The precise regulatory role of clusterin in renal apoptosis is still unknown, but the association is quite remarkable.
Protein Phosphorylation
Protein phosphorylation is a protein modification that regulates the activity of a number of cellular factors involved in apoptosis. The active state of the substrate protein ultimately determines the effect of phosphorylation on protein activity and the cellular response to the modification. Multiple phosphorylation-based signal transduction cascades, namely the MAPK family and stressactivated protein kinases, appear to be involved in mediating apoptosis in the kidney. A pattern of kinase activation (p38, extracellular regulatory kinase [ERK], and JNK) and stress response genes (c-jun, ATF-2) correlates with apoptosis in the kidney after ischemia reperfusion (160) . The importance of this correlation is underscored by the improvement in renal function and improved outcome of ischemic renal failure afforded by down-regulation of MAPK (106) . The precise role of kinase activation in ischemia reperfusion is still unclear because these kinases regulate proliferation and apoptosis.
Tyrosine phosphorylation may link numerous seemingly independent induction pathways of renal apoptosis such as hypoxia, glucose, and nitric oxide. D-Glucose increases apoptosis and decreases replication in cultured metanephroi by perturbing phosphorylation of proteins that regulate perlecan (a mediator of epithelial mesenchymal interaction) (53) . Similarly, nitric oxide stimulates JNK activity in glomerular mesangial cells, which was attenuated by genistein and N-acetylcysteine (97) . In addition, chemical hypoxia (antimycin A and substrate deprivation) caused cell death and induced an increase in protein tyrosine kinase activity and protein tyrosine phosphorylation in LLCPKI cells, which was also inhibited by genistein. All of these cases support a role for protein phosphorylation as a common link in various mechanisms of apoptosis in renal cells.
Protein phosphatases, PP and PP2A, appear to regulate proliferation in early embryonic kidney with PP1 and PP2A expression highest in El 5 kidney (130). Inhibition of PP 1 and PP2A activity by okadaic acid inhibited growth and nephron formation and induced apoptosis of developing nephrons. Similarly, okadaic acid induced apoptosis of renal epithelial cells in culture (17) . Calcineurin, a calcium-dependent protein phosphatase, appears to regulate calcium-induced apoptosis in renal cells deprived of growth factors, which are dependent on calcineurin's phosphatase activity (116) . The inhibition of phosphatase activity by okadaic acid was accompanied by an increase in various kinase activities (16) . Thus the induction of apoptosis by phosphatase inhibitors may be due to the loss of phosphatase activity and the concomitant activation of kinases. In neurons, a balance between growth factor-activated ERK and p38/JNK is proposed to be the switch for apoptosis or cell proliferation (159) . A similar balance in kinase and phosphatase activity may be regulatory in renal cells. Kinase signaling pathways are especially relevant to toxicants because they are the major intracellular transducers for extracellular factors (i.e., growth factors, Fas) and thus can be employed by a number of exogenous chemicals.
APOPTOSIS IN THE KIDNEY: GOALS FOR TOXICOLOGIC PATHOLOGISTS
The &dquo;gold standard&dquo; for initial identification of apoptosis continues to be cell morphology. The name selected for the process was based on the morphology of the dying cell, and the pathologist is uniquely suited to recognize and characterize these morphologic changes. Many of the molecular factors identified thus far appear to be responsible for specific morphologic changes such as changes in cell volume or DNA fragmentation. The results discussed here emphasize the importance of apoptosis in the kidney and the toxicologic pathologist will convey the potential functional consequences of toxicant or pharmacologic regulation of the process. The ongoing challenge is to observe novel pharmacologic agents for novel induction pathways that can be identified (in some cases via serendipity) by these agents. Because many pharmacologic agents function at specific points in the cell cycle or have specific intracellular targets, they will provide a direct link to drug design and strategies that enhance or suppress apoptosis. We should look forward to seeing the use of these agents extended to therapeutic control of viral infection, cancer or developmental abnormalities.
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